Isosorbide Mononitrate Activase Pharmaceuticals

Isosorbide mononitrate, the active ingredient in Isosorbide Mononitrate Activase Pharmaceuticals, is an organic nitrate vasodilator presented as an oral dosage form for systemic use. It is indicated for the prevention and treatment of chronic stable angina and angina pectoris in adult patients.

GNH USA supplies Isosorbide Mononitrate Activase Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide mononitrate acts within the anti‑anginal drug class to improve myocardial oxygen balance. - Chronic stable angina: reduces the frequency and severity of angina attacks. - Angina pectoris: enhances exercise tolerance by decreasing cardiac workload. - Prevention of angina episodes: provides sustained nitrate therapy to maintain symptom control.

Isosorbide mononitrate may cause a range of adverse reactions.

Common Side Effects: - Headache: often transient and dose‑related. - Dizziness or light‑headedness. - Flushing of the skin. - Nausea or mild gastrointestinal upset. - Palpitations or tachycardia.

Serious or Rare Side Effects: - Severe hypotension leading to syncope. - Allergic reactions such as rash, pruritus, or angioedema. - Myocardial infarction precipitated by abrupt nitrate withdrawal. - Life‑threatening hypotensive crisis when combined with phosphodiesterase‑5 inhibitors. - Unexplained chest pain or worsening angina.

Before initiating therapy, clinicians should evaluate cardiovascular status and potential contraindications. - Assess blood pressure: monitor for excessive drops after the first dose. - Review concomitant antihypertensive agents: adjust doses to avoid additive hypotension. - Avoid sudden discontinuation: taper to prevent rebound angina. - Use with caution in hepatic impairment: metabolism may be reduced. - Use with caution in renal impairment: excretion may be altered. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Isosorbide mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other organic nitrates (e.g., nitroglycerin): risk of profound hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe drops in blood pressure. - Potent CYP3A4 inhibitors (e.g., ketoconazole): can increase nitrate levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors, calcium channel blockers): additive blood‑pressure lowering effect. - Diuretics: may enhance volume depletion and hypotension. - Alcohol and tobacco: alcohol can increase hypotensive risk; tobacco induces nitrate metabolism, reducing efficacy.